术前C反应蛋白血清水平作为附件肿块患者的预测诊断标志物
研究评估术前C反应蛋白(CRP)血清水平作为附件肿块患者卵巢癌预测标志物的价值,纳入1843例附件肿块手术患者,其中良性卵巢肿瘤1423例、卵巢交界性肿瘤(BTO)83例、上皮性卵巢癌(EOC)337例。结果显示CRP与CA-125联合检测的敏感度和特异度分别为80.1%和90.8%,CRP血清水平独立预测BTO和EOC的存在,可能作为CA-125的补充用于术前鉴别诊断。
要点
- 良性卵巢肿瘤、BTO和EOC患者的中位CRP水平分别为0.4、0.5和1.6 mg/dL(p<0.001)。
- CRP与CA-125联合检测的敏感度80.1%、特异度90.8%,NPV 92.2%、PPV 76.9%。
- CRP血清水平独立预测BTO(HR 6.7)和EOC(HR 2.2)的存在(p<0.001)。
核心结论
- CRP血清水平独立预测可疑附件肿块患者中BTO和EOC的存在。
- CRP血清水平似乎对CA-125有附加价值,尤其与CA-125联合时可能在术前鉴别诊断中有临床用处。
研究设计与样本
- 研究纳入1843例附件肿块并接受后续手术的患者,其中良性卵巢肿瘤1423例、BTO 83例、EOC 337例。
- 通过单变量分析和多变量二元逻辑回归模型研究CRP血清水平的检验特征和预测价值。
主要发现
- 良性卵巢肿瘤、BTO和EOC患者的中位(四分位距)血清CRP水平分别为0.4(0.1-0.6)mg/dL、0.5(0.2-0.9)mg/dL和1.6(0.5-5.4)mg/dL(p<0.001)。
- CRP与CA-125联合检测的敏感度和特异度分别为80.1%和90.8%,阴性预测值和阳性预测值分别为92.2%和76.9%。
- 在单变量和多变量分析中,CRP血清水平独立与BTO的存在相关(HR 6.7 [5.2-8.5],p<0.001),与EOC的存在相关(HR 2.2 [1.4-3.3],p<0.001)。
- CRP与CA-125血清水平联合检测发现一例EOC或BTO的需治疗人数为2.11。
临床怎么用
- 作者认为CRP血清水平似乎对CA-125有附加价值,可能在附件肿块的术前鉴别诊断中有临床用处,尤其与CA-125联合时。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate C-reactive protein (CRP) serum levels as a preoperative predictive marker for ovarian cancer in patients with adnexal masses. METHODS: CRP serum levels of 1843 adnexal masses and subsequent surgery were investigated (patients with benign ovarian tumors: n=1423; borderline tumor of the ovary [BTO]: n=83; EOC: n=337). Test characteristics and predictive values of CRP serum levels were investigated by univariate analysis and multivariate binary logistic regression models. RESULTS: Median (interquartile range) serum CRP levels in patients with benign ovarian tumors, BTO, and EOC were 0.4 (0.1-0.6)mg/dL, 0.5 (0.2-0.9)mg/dL, and 1.6 (0.5-5.4)mg/dL, respectively (p<0.001). Sensitivity and specificity of the combination of CRP and CA-125 was 80.1% and 90.8%, negative predictive value (NPV) and positive predictive value (PPV) was 92.2% and 76.9%, respectively. In univariate and multivariate analysis, CRP serum levels were independently associated with presence of BTO and EOC (HR 6.7 [5.2-8.5], p<0.001 and HR 2.2 [1.4-3.3], p<0.001). The combination of CRP and CA-125 serum levels resulted in a number needed to treat of 2.11 to detect one case of EOC or BTO. CONCLUSION: CRP serum levels independently predicted the presence of BTO and EOC in patients with suspicious adnexal masses. CRP serum levels seem to be of additional value to CA-125 in the preoperative differential diagnosis of adnexal masses and might be particularly in combination with CA-125 clinically useful.
引用
- Reiser E, Aust S, Seebacher V, et al. Preoperative C-reactive protein serum levels as a predictive diagnostic marker in patients with adnexal masses. Gynecol Oncol. 2017. PMID: 28935270. doi:10.1016/j.ygyno.2017.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。